HEXO’s (TSX:HEXO) Stock Rebound Could Be Legendary

HEXO Corp. (TSX:HEXO)(NYSE:HEXO) is building a differentiated pot business capable of generating more than $1 billion in sales. A recent pullback could be your chance to strike.

| More on:
Cannabis stocks have fallen.

HEXO (TSX:HEXO)(NYSE:HEXO) was once one of the hottest stocks in the emerging cannabis industry. In 2016, shares were priced at just $0.50. This May, they topped $10.

The rise was incredible, but the recent cannabis bear market has hit the stock hard. Shares recently touched $2.50 apiece. To be fair, nearly every pot stock has been hit hard. Marijuana ETFs have fallen by more than 50% from their peaks.

Expectations for HEXO were certainly too high this summer, but following the decline, expectations now seem too low.

This fiscal year, analysts expect the company to generate $110 million in sales. Next fiscal year, analysts anticipate $230 million in sales. With a market cap of just $750 million, the stock is a screaming bargain if these projections come true.

And that’s just the next year or two. Over the long term, HEXO is building a differentiated business capable of generating at least $1 billion in sales.

Have to be different

This summer, I’d warned investors about the impending cannabis supply glut. “Take a look at most pot stocks, and you’ll discover one thing: the majority are trying to ramp cannabis production as quickly as possible,” I wrote. Indeed, weak pricing has been a major factor behind the recent market slump.

“The key to success will not be production growth,” I noted, “but differentiation.” Today, most pot companies are focused on proving why they’ll maintain pricing power, even as industry supply ramps. Canopy Growth, for example, is looking to create value-add, cannabis-infused beverages. Green Organic Dutchman Holdings has gone all-in on organic products.

But there are ways to differentiate yourself beyond building branded products. If you dig in, HEXO is building something truly special.

Building a giant

This decade, tech companies have perfected a model for creating multi-billion-dollar businesses: platforming. Microsoft and Shopify are popular examples. Microsoft, with its Windows operating system, and Shopify, with its e-commerce platform, have built products that other companies can build on top of.

Think of all the applications and businesses built on top of each respective platform. Without Microsoft or Shopify, they’d disappear instantly. That’s the power of a platform; it creates a super-sticky revenue model with intense customer retention.

Taking a cue from tech, HEXO is building the first cannabis platform. Instead of selling directly to consumers, the company is focused on building backend infrastructure capable of supporting the needs of other businesses.

Let’s say Coca-Cola wants to create cannabis-infused sodas, but doesn’t want to deal with the regulatory and capital-expense issues related to building its own private cannabis segment. Instead, it can simply partner with HEXO, which can use its existing infrastructure to research, develop, manufacture, package, and distribute Coke-branded cannabis products. It’s as simple as that.

Already, HEXO has attracted top-tier customers like Molson Coors Canada. In 2020, it wants to acquire additional Fortune 500 partners in new verticals like sleep aids, cosmetics, edibles, and more.

This hub and spoke model — with HEXO as the central hub and external partners as the spokes — is new to the cannabis industry, but it’s been proven in other markets. If it gains traction next year, HEXO stock could go gangbusters. That’s because it no longer needs to tap the market opportunity by itself. Instead, it’ll have pre-existing global partners ready to hit the ground running.

What’s more likely to succeed: a cannabis product from an upstart brand, or a cannabis product from a well-known global powerhouse? HEXO is betting on the latter.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Teresa Kersten, an employee of LinkedIn, a Microsoft subsidiary, is a member of The Motley Fool’s board of directors. Tom Gardner owns shares of Shopify. The Motley Fool owns shares of and recommends Microsoft, Shopify, and Shopify. The Motley Fool owns shares of Molson Coors Brewing. The Motley Fool recommends HEXO. and HEXO and recommends the following options: long January 2021 $85 calls on Microsoft. Fool contributor Ryan Vanzo has no position in any stocks mentioned. 

More on Cannabis Stocks

Pot stocks are a riskier investment
Cannabis Stocks

Is the Worst Over for Canopy Growth Stock?

Down 99% from all-time highs Canopy Growth stock has burnt investor wealth and remains a high-risk investment.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

Steer Clear: This Stock Spells Trouble

A newly listed cannabis stock is outperforming in 2024 but investors should stay clear to avoid trouble and losses.

Read more »

Cannabis stocks have fallen.
Cannabis Stocks

2 Best Marijuana Stocks to Buy This Month

Marijuana stocks in the U.S. such as Green Thumb and Curaleaf can help you deliver outsized gains to investors in…

Read more »

A cannabis plant grows.
Cannabis Stocks

Can Aurora Cannabis Stock Recover in 2024?

Aurora Cannabis stock is down 99% from all-time highs but remains a high-risk bet, despite its cheap valuation.

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

The Best Cannabis Stock to Buy Right Now

This cannabis stock has jumped 30% in the last few months, with even more growth on the way – all…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Down 99% From All-Time Highs, Is Canopy Growth Stock a Good Buy Right Now?

Canopy Growth stock is a high-risk investment due to its negative profit margins and challenging liquidity position.

Read more »

Marijuana plant and cannabis oil bottles isolated
Stocks for Beginners

Aurora Cannabis’ Reverse Stock Split: Is the Stock a Buy Today?

Cannabis stock Aurora (TSX:ACB) is consolidating shares once again, but what does this mean for investors?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Where Will Cannabis Stocks Be in 10 Years?

Cannabis stocks could see a huge shift upwards should marijuana be rescheduled in the U.S., but you can still buy…

Read more »